COVID-19 is a key aim of GenOMICC

Susceptibility to COVID-19 is almost certainly, in part, genetic. GenOMICC can find the genes that cause susceptibility, which may help us to prioritise treatments to respond to the global crisis. GenOMICC was designed for this crisis. Since 2016, the open, global GenOMICC collaboration has been recruit patients with emerging infections, including COVID-19. All critically-ill patients with confirmed COVID-19 are eligible for GenOMICC. Please recruit them as normal, following local infection control precautions.

GenOMICC is prioritised as an NIHR Urgent Public Health Study in the UK

Establish GenOMICC in your region

GenOMICC set-up is designed to make it easy for you to run your own study of the genetic factors underlying critical illness. This can be in collaboration with us, or independent - it's up to you. Our hope is that, ultimately, we will be able to work together either to replicate findings, or to combine genetic signals, in order to make discoveries that advance our understanding of critical illness.

Setting up

Click to see the full study protocol and related documents.

To establish recruitment, you will need to obtain local/regional ethical and management approval (from a research ethics board, institutional review board or equivalent). In different legal jusrisdictions this may require some changes to the consent forms. Recruiting a patient is easy and takes very little research nurse time - around 1h in total is a reasonable estimate, including follow-up. DNA extraction and genotyping can be done in a local or national lab. It is usually easier to do this within the country that the patient was recruited from.


Funding

We are very grateful to receive funding from the Fiona Elizabeth Agnew Trust (FEAT), the Wellcome Trust, and the UK Intensive Care Society in support of the GenOMICC study.


Contact us: genomicc@roslin.ed.ac.uk